Pet Cardiovascular Health Supplement Market  Outlook

NEWARK, Del., October 8, 2026. — The global pet cardiovascular health supplement market is estimated at USD 2.5 billion in 2026 and is projected to reach USD 4.4 billion by 2036, expanding at a CAGR of 5.8% from 2026 to 2036, according to Future Market Insights (FMI).

The market is being shaped by growing awareness of preventive pet healthcare and rising demand for targeted cardiovascular support. FMI says the sector is moving beyond basic general wellness supplements toward specialized formulations that combine evidence-based ingredients, improved bioavailability and veterinary-guided use across dogs, cats and other companion animals.

Preventive cardiac care is reshaping supplement demand

Pet owners and veterinary professionals are increasingly focusing on cardiovascular health as part of broader preventive care programs. This is encouraging manufacturers to develop products containing specialized compounds such as omega-3 fatty acids, taurine, L-carnitine, CoQ10 and selected herbal actives.

FMI says advances in nutraceutical research and veterinary science are allowing manufacturers to improve delivery mechanisms, standardize active ingredient concentrations and develop formulations designed for targeted cardiac support. Palatability, dosing convenience and product safety are also becoming important as pet supplements are used over extended periods.

👉 Get Detailed Market Forecasts, Competitive Benchmarking & Pricing Trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-32037

Where growth is fastest

·         China — 8.1% CAGR: Rapid expansion of companion animal healthcare infrastructure and premiumization of pet care are expected to make China the fastest-growing market through 2036. Increasing access to specialized veterinary services is supporting demand for targeted cardiovascular health products.

·         USA — Leading value share: The United States remains a major market, supported by high clinical validation standards, advanced therapeutic innovation and established veterinary healthcare infrastructure. Demand for evidence-based products is encouraging manufacturers to develop more specialized cardiovascular formulations.

What leads the market

·         Targeted cardiovascular formulations: Specialized products designed around specific cardiac health requirements are gaining attention as pet owners increasingly seek preventive and therapeutic support beyond general wellness.

·         Soft chews, capsules, powders and liquids: Multiple dosage formats allow manufacturers to address differences in animal size, species, palatability preferences and administration requirements.

·         Veterinary channels: Veterinary clinics and professional recommendations are becoming increasingly important as consumers seek greater confidence in the safety, efficacy and appropriate use of cardiovascular supplements.

·         Online and specialty retail: Direct-to-consumer and specialist pet retail channels are expanding access to targeted formulations while allowing brands to communicate ingredient information and product benefits directly to pet owners.

The hurdle

Clinical validation and product credibility remain central to market adoption. FMI says the market is shifting toward clinically validated and veterinary-recommended formulations, increasing the importance of evidence, standardized active ingredients, appropriate dosing and safety information. Manufacturers seeking to move beyond general wellness positioning must demonstrate a clear product purpose and build confidence among both pet owners and veterinary professionals.

For full coverage of the Pet Cardiovascular Health Supplement Market, including forecasts by ingredient, product type, animal type, distribution channel, region and country, visit the FMI report:

Recent developments

The market is seeing product portfolio expansion and stronger movement toward veterinary-focused distribution:

·         January 2026: Zesty Paws expanded its product offerings, reflecting the broader shift toward science-led pet health solutions and veterinary channel expansion. Akash Bedi, CEO for North America, Middle East and India at H&H Group, described the company's entry into the veterinary channel as a natural evolution of its science-focused commitment.

·         2026: Manufacturers are increasingly investing in advanced nutraceutical research, bioavailability enhancement and standardized active ingredient concentrations to support targeted cardiovascular applications.

·         Ongoing market development: Specialized providers are strengthening relationships with veterinary practices and direct-to-consumer channels, creating opportunities for customized cardiovascular support across canine, feline and small mammal healthcare.

FMI profiles Nutramax Laboratories, VetriScience and Nordic Naturals among the key companies operating in the pet cardiovascular health supplement market. Competition is being shaped by portfolio expansion, strategic acquisitions, veterinary-grade solutions and distribution network development.

Analyst perspective

“The pet cardiovascular health supplement market is moving from general wellness toward targeted, evidence-based support. As pet owners become more proactive about preventive care, clinically validated formulations can create new opportunities for manufacturers.”— Nandini Roy Choudhury, Principal Consultant, Future Market Insights.

What this means for pet health manufacturers and supplement brands

·         Prioritize evidence-based formulations. Products built around targeted cardiovascular ingredients and standardized active concentrations can address growing demand for more specialized pet health solutions.

·         Strengthen veterinary engagement. Veterinary recommendations can improve product credibility and support adoption as consumers seek professional guidance for preventive cardiac care.

·         Improve palatability and dosing convenience. Soft chews, liquids, powders and other convenient formats can help manufacturers address compliance challenges across different animal types.

·         Develop advanced delivery systems. Bioavailability enhancement and improved ingredient delivery can help differentiate products as the market moves toward more targeted cardiovascular support.

·         Expand beyond general wellness. Manufacturers can pursue opportunities in breed-specific, age-related and condition-focused formulations as pet healthcare becomes increasingly preventive and specialized.

Future Market Insights, Inc. (FMI) is an ESOMAR-certified market research and consulting firm headquartered in Delaware, USA, with offices in the United Kingdom, the United Arab Emirates and India. FMI delivers syndicated and custom research across food and beverage, healthcare, chemicals, technology, packaging, consumer goods and industrial sectors.

For Press & Corporate Inquiries

Rahul Singh
AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075

For Sales: sales@futuremarketinsights.com

For Media: Rahul.singh@futuremarketinsights.com